LADU, SARA
 Distribuzione geografica
Continente #
NA - Nord America 802
EU - Europa 697
AS - Asia 681
SA - Sud America 78
AF - Africa 12
Totale 2.270
Nazione #
US - Stati Uniti d'America 785
CN - Cina 281
SG - Singapore 199
UA - Ucraina 139
TR - Turchia 119
IE - Irlanda 107
GB - Regno Unito 95
SE - Svezia 83
FR - Francia 70
BR - Brasile 66
DE - Germania 57
IT - Italia 55
FI - Finlandia 32
IN - India 30
RU - Federazione Russa 22
VN - Vietnam 20
CA - Canada 11
HK - Hong Kong 10
AR - Argentina 8
AT - Austria 7
BD - Bangladesh 7
LT - Lituania 7
CZ - Repubblica Ceca 6
ZA - Sudafrica 5
ES - Italia 4
GR - Grecia 4
IL - Israele 4
MX - Messico 4
PL - Polonia 4
MA - Marocco 3
EG - Egitto 2
HN - Honduras 2
IQ - Iraq 2
KR - Corea 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
NL - Olanda 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 2.270
Città #
Jacksonville 168
Chandler 137
Singapore 137
Dublin 106
Beijing 93
Southend 80
Princeton 57
Nanjing 56
Izmir 43
Ashburn 36
Dallas 36
Altamura 35
Cambridge 28
Boardman 23
Tongling 23
Nanchang 22
Wilmington 21
Los Angeles 17
Santa Clara 16
Kunming 15
Buffalo 12
Shenyang 11
Ho Chi Minh City 10
Hong Kong 10
Tianjin 9
Dearborn 8
Hebei 6
London 6
Olomouc 6
Chieti 5
Jiaxing 5
New York 5
Norwalk 5
Redondo Beach 5
The Dalles 5
Changchun 4
Chicago 4
Frankfurt am Main 4
Hangzhou 4
Hanoi 4
Hefei 4
Helsinki 4
Manchester 4
Rio de Janeiro 4
San Francisco 4
Toronto 4
Vienna 4
Atlanta 3
Boston 3
Changsha 3
Johannesburg 3
Lanzhou 3
Montreal 3
Nuremberg 3
Ottawa 3
Stockholm 3
Warsaw 3
Brooklyn 2
Buenos Aires 2
Campinas 2
Chennai 2
Curitiba 2
Grevenbroich 2
Hyderabad 2
Kolkata 2
Lima 2
Munich 2
Orem 2
Porto Alegre 2
Recife 2
Seoul 2
Shanghai 2
Adana 1
Ahmedabad 1
Algiers 1
Amsterdam 1
Andover 1
Ankara 1
Ann Arbor 1
Apo 1
Bady Bassitt 1
Belo Horizonte 1
Bengaluru 1
Berlin 1
Birmingham 1
Bismarck 1
Bogotá 1
Bom Despacho 1
Bom Jesus 1
Brasília 1
Broummâna 1
Brussels 1
Cachoeiro de Itapemirim 1
Cairo 1
Campeche 1
Campo Grande 1
Cape Town 1
Casablanca 1
Cascavel 1
Ciudad Juárez 1
Totale 1.393
Nome #
The SHP-1 expression is associated with cytokines and psychopathological status in unmedicated first episode schizophrenia patients 133
V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis 99
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. 92
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. 89
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. 89
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. 85
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. 85
Disregulation of E-cadherin in transgenic mouse models of liver cancer. 84
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. 84
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. 83
Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. 83
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. 82
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease. 81
Oncogenic and tumor suppressive roles of Polo-like kinases in human hepatocellular carcinoma (p NA). 80
Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. 80
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. 79
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 76
Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. 76
Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. 74
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. 74
Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. 74
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis. 73
Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis. 73
Yes-Associated Protein Upregulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma. 73
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways 72
Downregulation of PH domain leucine-rich repeat protein phosphatases (PHLPPs) identifies a subgroup of human hepatocellular and colorectal carcinomas with elevated levels of activated AKT and low apoptosis rate 72
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 71
Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. 70
Totale 2.286
Categoria #
all - tutte 10.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 30 0 1 4 25 0 2
2021/2022101 0 0 0 19 8 0 3 4 13 3 15 36
2022/2023422 30 52 26 43 47 96 24 36 56 1 3 8
2023/2024121 22 5 1 1 9 38 32 0 0 0 1 12
2024/2025329 25 36 47 5 0 31 0 40 9 11 50 75
2025/2026384 88 46 86 79 58 27 0 0 0 0 0 0
Totale 2.286